Barclays’s Dare Bioscience DARE Stock Holding History

Barclays’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$523	Buy	+248	New	+$554	﹤0.01%	5003
2021 Q2	–	Sell	-29	Closed	-$1K	–	4904
2021 Q1	$1K	Buy	+29	New	+$707	﹤0.01%	4587
2019 Q1	–	Sell	-1,167	Closed	-$10K	–	7057
2018 Q4	$10K	Buy	1,167 +700	+150%	+$7.37K	﹤0.01%	6164
2018 Q3	$5K	Sell	467 -200	-30%	-$2.69K	﹤0.01%	6773
2018 Q2	$9K	Sell	667 -666	-50%	-$8.89K	﹤0.01%	6569
2018 Q1	$13K	Buy	+1,333	New	+$27K	﹤0.01%	6578

Other funds holding DARE

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Barclays's DARE Position: Q2 2026 in Review

Barclays opened a new position in Dare Bioscience (DARE) in Q2 2026: 248 shares worth $523. The stake represents ﹤0.01% of the portfolio and ranks #5003 among its holdings. This is a return to the name: Barclays previously reported a position in DARE as recently as Q1 2021.

Barclays first reported a position in DARE in Q1 2018 and has held it in 6 quarters since. The position peaked at $13K in Q1 2018. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

Barclays held 248 shares of Dare Bioscience worth $523 as of Q2 2026.
Dare Bioscience was a new Barclays position in Q2 2026.
Dare Bioscience made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5003 holding.
Barclays first reported a position in Dare Bioscience in Q1 2018 and has held it in 6 quarters since.
Barclays's Dare Bioscience position peaked at $13K in Q1 2018.
27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.